(IAC) IAC - Overview
Stock: Digital Media, Magazines, Home Services, Search, Caregiving, Film
| Risk 5d forecast | |
|---|---|
| Volatility | 35.0% |
| Relative Tail Risk | -10.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | -10.64 |
| Character TTM | |
|---|---|
| Beta | 1.010 |
| Beta Downside | 0.905 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.81% |
| CAGR/Max DD | -0.19 |
EPS (Earnings per Share)
Revenue
Description: IAC IAC January 11, 2026
IAC Inc. (NASDAQ:IAC) is a diversified media and internet conglomerate that monetizes a portfolio of consumer-focused digital brands. Its core assets include lifestyle and women’s media (People, Better Homes & Gardens, Real Simple, etc.), a home-services marketplace (Angi Ads & Leads, Angi Services), search-and-shopping portals (Ask.com, Reference.com, ConsumerSearch.com, Shopping.net), caregiving platforms (Care.com, HomePay), a health-professionals job board (Vivian Health), news and culture site (The Daily Beast), and film-production services (IAC Films). The company generates revenue primarily through advertising, subscription fees, and transaction commissions across these verticals.
Recent performance highlights (Q2 2024) show revenue of approximately $2.2 billion, a 5 % year-over-year increase driven largely by a rebound in digital ad spend and strong growth in the Angi Services segment, which posted a 12 % rise in transaction volume. The home-services market is expanding at a 4–5 % CAGR globally, providing a tailwind for Angi’s marketplace model. Meanwhile, the broader interactive media sector remains sensitive to macro-economic cycles, with advertising budgets typically lagging GDP growth by 3–4 months; this lag is a key risk factor for IAC’s media properties.
For a deeper, data-driven look at IAC’s valuation metrics and scenario analysis, you might find ValueRay’s platform useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -104.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -2.79 > 1.0 |
| NWC/Revenue: 41.11% < 20% (prev 45.66%; Δ -4.55% < -1%) |
| CFO/TA 0.01 > 3% & CFO 64.0m > Net Income -104.0m |
| Net Debt (465.6m) to EBITDA (213.4m): 2.18 < 3 |
| Current Ratio: 2.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.6m) vs 12m ago -6.65% < -2% |
| Gross Margin: 66.81% > 18% (prev 0.70%; Δ 6611 % > 0.5%) |
| Asset Turnover: 28.70% > 50% (prev 36.68%; Δ -7.98% > 0%) |
| Interest Coverage Ratio: -1.17 > 6 (EBITDA TTM 213.4m / Interest Expense TTM 120.0m) |
Altman Z'' 0.20
| A: 0.14 (Total Current Assets 1.54b - Total Current Liabilities 560.9m) / Total Assets 7.13b |
| B: -0.09 (Retained Earnings -643.0m / Total Assets 7.13b) |
| C: -0.02 (EBIT TTM -140.6m / Avg Total Assets 8.34b) |
| D: -0.28 (Book Value of Equity -654.8m / Total Liabilities 2.34b) |
| Altman-Z'' Score: 0.20 = B |
Beneish M -2.98
| DSRI: 1.26 (Receivables 448.8m/519.7m, Revenue 2.39b/3.50b) |
| GMI: 1.05 (GM 66.81% / 70.09%) |
| AQI: 1.06 (AQ_t 0.74 / AQ_t-1 0.70) |
| SGI: 0.68 (Revenue 2.39b / 3.50b) |
| TATA: -0.02 (NI -104.0m - CFO 64.0m) / TA 7.13b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of IAC shares?
Over the past week, the price has changed by +0.06%, over one month by -9.91%, over three months by +5.62% and over the past year by +6.17%.
Is IAC a buy, sell or hold?
- StrongBuy: 7
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.8 | 31.1% |
| Analysts Target Price | 46.8 | 31.1% |
| ValueRay Target Price | 35.4 | -0.9% |
IAC Fundamental Data Overview February 08, 2026
P/S = 1.1535
P/B = 0.5821
P/EG = 13.6232
Revenue TTM = 2.39b USD
EBIT TTM = -140.6m USD
EBITDA TTM = 213.4m USD
Long Term Debt = 1.41b USD (from longTermDebt, two quarters ago)
Short Term Debt = 24.5m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 465.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.23b USD (2.76b + Debt 1.43b - CCE 960.2m)
Interest Coverage Ratio = -1.17 (Ebit TTM -140.6m / Interest Expense TTM 120.0m)
EV/FCF = 71.96x (Enterprise Value 3.23b / FCF TTM 44.8m)
FCF Yield = 1.39% (FCF TTM 44.8m / Enterprise Value 3.23b)
FCF Margin = 1.87% (FCF TTM 44.8m / Revenue TTM 2.39b)
Net Margin = -4.35% (Net Income TTM -104.0m / Revenue TTM 2.39b)
Gross Margin = 66.81% ((Revenue TTM 2.39b - Cost of Revenue TTM 794.3m) / Revenue TTM)
Gross Margin QoQ = 72.20% (prev 64.83%)
Tobins Q-Ratio = 0.45 (Enterprise Value 3.23b / Total Assets 7.13b)
Interest Expense / Debt = 1.89% (Interest Expense 26.9m / Debt 1.43b)
Taxrate = 21.0% (US default 21%)
NOPAT = -111.1m (EBIT -140.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.75 (Total Current Assets 1.54b / Total Current Liabilities 560.9m)
Debt / Equity = 0.30 (Debt 1.43b / totalStockholderEquity, last quarter 4.73b)
Debt / EBITDA = 2.18 (Net Debt 465.6m / EBITDA 213.4m)
Debt / FCF = 10.39 (Net Debt 465.6m / FCF TTM 44.8m)
Total Stockholder Equity = 4.79b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.25% (Net Income -104.0m / Total Assets 7.13b)
RoE = -2.17% (Net Income TTM -104.0m / Total Stockholder Equity 4.79b)
RoCE = -2.27% (EBIT -140.6m / Capital Employed (Equity 4.79b + L.T.Debt 1.41b))
RoIC = -1.78% (negative operating profit) (NOPAT -111.1m / Invested Capital 6.25b)
WACC = 6.86% (E(2.76b)/V(4.19b) * Re(9.64%) + D(1.43b)/V(4.19b) * Rd(1.89%) * (1-Tc(0.21)))
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.76%
[DCF Debug] Terminal Value 75.71% ; FCFF base≈157.5m ; Y1≈103.4m ; Y5≈47.2m
Fair Price DCF = 9.72 (EV 1.16b - Net Debt 465.6m = Equity 695.0m / Shares 71.5m; r=6.86% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 43.17 | EPS CAGR: 20.06% | SUE: -0.57 | # QB: 0
Revenue Correlation: -87.15 | Revenue CAGR: -17.44% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.27 | Chg30d=-0.117 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=0.49 | Chg30d=-0.135 | Revisions Net=+1 | Growth EPS=+138.0% | Growth Revenue=-4.8%
EPS next Year (2027-12-31): EPS=1.14 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+131.5% | Growth Revenue=+1.0%